TrialClinical drug investigation2018

Multicenter, Open-Label Study of Long-Term Topiroxostat (FYX-051) Administration in Japanese Hyperuricemic Patients with or Without Gout.

Tatsuo Hosoya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.